Dr. Reddy's family trusts acquire significant shareholding for succession

On September 18, 2025, Dr. Reddy's Laboratories announced its promoters, Satish Reddy Kallam and G V Prasad, transferred a significant portion of their equity shares to two family trusts. This off-market transfer, executed on September 17, 2025, involved 17,17,26,540 equity shares of INR 1/- each, representing an aggregate of 20.58% of the company's total share capital. Satish Reddy Kallam transferred 7,56,30,620 shares (9.06%) to VSD Family Trust, while G V Prasad transferred 9,60,95,920 shares (11.51%) to GVP Family Trust.

This transaction is described as a private family arrangement for succession planning and asset streamlining, carried out under an exemption from SEBI dated December 31, 2024. The shares involved in this transfer had undergone a five-for-one stock split from INR 5/- to INR 1/- face value, effective October 28, 2024.

Despite the transfer to the trusts, there is no change in the overall shareholding of the promoter group in Dr. Reddy's Laboratories Limited. The company's equity shares are listed on the BSE Ltd and NSE Ltd.